Page
%P
1 Result(s)
-
Article
Open AccessmiR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
Post-resistance progress in paclitaxel (PTX) treatment remains a major challenge in tumor treatment. A high dose of PTX was used for cell lines to analyze the changes in molecular expression. The miR-378d was ...
